These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7931220)

  • 1. Synergistic sedative effect of selective MAO-A, but not MAO-B, inhibitors and melatonin in frogs.
    Requintina PJ; Oxenkrug GF; Yuwiler A; Oxenkrug AG
    J Neural Transm Suppl; 1994; 41():141-4. PubMed ID: 7931220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.
    Gerardy J
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):793-802. PubMed ID: 7938567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; McIntyre IM; White K
    J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methylene blue and related redox dyes on monoamine oxidase activity; rat pineal content of N-acetylserotonin, melatonin, and related indoles; and righting reflex in melatonin-primed frogs.
    Oxenkrug GF; Sablin SO; Requintina PJ
    Ann N Y Acad Sci; 2007 Dec; 1122():245-52. PubMed ID: 18077577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
    Oxenkrug GF; Requintina PJ; Yuwiler A
    J Neural Transm Suppl; 1990; 32():171-5. PubMed ID: 2089086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
    Murphy DL; Tamarkin L; Sunderland T; Garrick NA; Cohen RM
    Psychiatry Res; 1986 Feb; 17(2):119-27. PubMed ID: 3008207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
    Fisar Z; Hroudová J; Raboch J
    Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.
    Weinstock M; Gorodetsky E; Wang RH; Gross A; Weinreb O; Youdim MB
    Neuropharmacology; 2002 Nov; 43(6):999-1005. PubMed ID: 12423669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
    Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible melatonin involvement in the hypotensive effect of MAO inhibitors.
    Oxenkrug GF; McCauley RB; Fontana DJ; McIntyre IM; Commissaris RL
    J Neural Transm; 1986; 66(3-4):271-80. PubMed ID: 3097249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular hypotensive effects of monoamine oxidase-A inhibitors in rabbit.
    Maeda I; Ueda T; Koide R; Inatomi M; Fukado Y; Uchida E; Oguchi K; Yasuhara H
    Jpn J Ophthalmol; 1988; 32(2):211-8. PubMed ID: 3184554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells.
    Youdim MB
    J Neurochem; 1990 Feb; 54(2):411-4. PubMed ID: 2299343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some characteristics of monoamine oxidase activity in tissues of the adult female grassfrog (Rana pipiens).
    Urueña G; Hall TR
    Comp Biochem Physiol C Comp Pharmacol; 1982; 73(1):67-70. PubMed ID: 6128181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB; Weinstock M
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of monoamine oxidase in monkey heart.
    Katayama M; Kobayashi S; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG; Baker GB
    J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.